Skip to main content

Table 1 Demonstration of CHIKV antigen in CSF of Neuro-CHIKV and Non-CHIKV group by ELISA method.

From: Detection of viral antigen, IgM and IgG antibodies in cerebrospinal fluid of Chikungunya patients with neurological complications

Study Subjects

Positivity for CHIKV Antigen (%)

Negativity for CHIKV Antigen (%)

Neuro-CHIKV patients (n = 46)

37 (80%)

9 (20%)

Confirmed (n = 9)

9 (100%)

0

   Encephalitis (n = 4)

4 (100%)

0

   Myelopathy (n = 2)

2 (100%)

0

   Myeloneuropathy (n = 1)

1 (100%)

0

   Peripheral Neuropathy (n = 1)

1 (100%)

0

   Myopathy (n = 1)

1 (100%)

0

Suspected (n = 37)

28 (76%)

9 (24%)

   Encephlitis (n = 20)

16 (80%)

4 (20%)

   Myelopathy (n = 5)

5 (100%)

0

   Myeloneuropathy (n = 6)

4 (67%)

2 (33%)

   Peripheral Neuropathy (n = 6)

3 (50%)

3 (50%)

Non-CHIKV patients (n = 15)

2 (13%)

13 (87%)